Advancing Women's Health with Precision Medicine
Transforming fragmented health data into an integrated clinical profile to better support women throughout their menopause transition.
The menopause transition presents a complex and fluctuating array of symptoms that complicates care management. AppMed™ streamlines consultations by consolidating patient-recorded real-time data with structured monitoring tools integrated into the clinical process.
Clinical Reality — Menopause care
40s
Menopausal symptoms frequently emerge in women during their 40s, a time when many are at the height of their careers and balancing significant family responsibilities. These symptoms can be disruptive enough to impact both their professional performance and overall quality of life.
– Whiteley, Womens Health 2013
80%
Women experience vasomotor symptoms during menopause
Iterative
Hormone therapy often requires individualized titration based on symptom response and tolerability
— SOGC / Canadian Menopause Society
The Clinical Gap
Where Women's
Health Care Fails
Menopause care is highly symptom-rich and treatment-sensitive, yet clinical follow-up still relies primarily on infrequent appointments and patients’ subjective memory.
01
The Pitfall of Recall Bias
Accurately recalling and reporting symptoms and menstrual patterns over several months is challenging for patients. Such recall bias can distort the clinical picture and contribute to less effective management.
02
Complex and fluctuating Clinical Presentation
Menopause unfolds over many years, but clinical data are typically collected only during brief, scheduled visits. These isolated snapshots, and the challenge of visualizing the complete symptom trajectory, can hinder optimal treatment decisions.
03
HRT Individualization Without Objective Data
A range of hormonal treatments is available, with dosing and routes of administration requiring careful consideration. In the absence of continuous, objective data, therapy adjustments may be delayed or less effective.
04
Lack of Accurate Adherence Data
Continuous adherence tracking provides actionable insights into patient prescription use. Early detection of non-adherence enables timely intervention, while alerts help patients manage complex dosing schedules
What AppMed™ Offers
Making Menopause Care Easy: Three Essential Streams
Continuous, objective data collected beyond the clinic setting can revolutionize menopause management. AppMed™ equips clinicians with real-time patient-reported outcomes, precise adherence tracking, and easy at-home microsampling for biomarker analysis when necessary.
Real-Time Monitoring of Symptoms and Menstrual Patterns
Validated menopause-specific questionnaires (MRS, MENQOL, Greene Climacteric Scale) are automatically submitted to patients between visits to capture real-time symptom trajectories that reflect daily life rather than just snapshots at appointments.
- Validated menopause PRO scales (MRS, MENQOL, Greene Climacteric Scale).
- Health Journal to track menstrual patterns and symptom frequency/intensity.
- Longitudinal PROs score trends to support clinical assessments.
- Population-level analytics for menopause program evaluation.
AppMed consolidates and synthesizes all clinical information into a comprehensive longitudinal profile, making data interpretation and clinical decision-making easier.
- Pre/Post-treatment symptoms burden.
- Treatment adverse events tracking
- Adherence alerts and log with connected medication dispensing systems (MDS).
HRT Monitoring
Longitudinal
Objective Treatment Response
Convenient At-Home
Hormone Sampling
When appropriate, patients can self-collect dried blood spot samples at home for monitoring hormonal panels. This approach reduces the need for repeat clinic visits while ensuring ongoing, objective clinical oversight.
- Home-based blood microsampling
- Objective monitoring of hormone levels
- Laboratory results seamlessly integrated into the AppMed™ patient dashboard.
The Clinical Pathways
The AppMed™ Advantage
in Menopause Care
AppMed™ enhances the quality of care in menopause clinical programs by providing dedicated monitoring protocols and specialized, validated patient-reported outcome (PRO) tools.
Menopause Pathway
Menopause Care & Symptom Management
Longitudinal, continuous monitoring of menopausal symptom burden, enabling evidence-based symptom management, treatment individualization, and earlier intervention for women with uncontrolled symptoms.
- Validated menopause PRO scales (MRS, MENQOL, Greene Climacteric Scale).
- Health Journal to track menstrual patterns and symptom frequency/intensity.
- Longitudinal PROs score trends to support clinical assessments.
- Automatic Friendly reminders to patients.
- Population-level menopause program analytics
- Monitoring of side effects and treatment tolerability.
Hormone therapy
Hormone Replacement Therapy Monitoring
Structured monitoring of HRT initiation, dose titration, and ongoing adherence, enabling clinicians to assess therapeutic response continuously and adjust treatment based on objective, longitudinal symptom and tolerability data.
- HRT adherence tracking (route, dose, timing)
- Pre- and post-treatment symptom comparison.
- Monitoring of side effects and treatment tolerability.
- Long-term therapy continuation support
- Optional at-home hormone analysis using microsampling (coming soon).
33%
waited more than two years after first noticing symptoms to receive effective treatment, while nearly 1/2 waited at least one year.
40%
say they did not know where to seek menopause or hormonal health care, while more than 1/4 did not initially recognize their symptoms as part of a hormonal transition.
64%
say menopause symptoms affect their job performance, and more than 1/2 say the time spent seeking care has disrupted their work.
— GreenShield survey conducted by Ipsos, 2026
What AppMed™ Captures
The Data That Makes Hormonal Care Individualized Women's Health Clinical Journey — AppMed™ Touchpoints
Validated Menopause PROs
MRS, MENQOL, Greene Climacteric Scale, structured, continuous, validated. Real symptom trajectories across all domains.
HRT Adherence & Tolerability
Medication logs, route tracking, and structured side effect monitoring, replacing subjective recall with objective data.
Coming soon
Hormonal Panel Microsampling
Optional, at-home fingerprick sample collection for estrogen/progesterone monitoring, no clinic visit required for routine oversight.
Onboarding & Baseline Assessment
Symptom profile established using validated scales. Consent captured. HRT plan configured in AppMed™.
Continuous Symptom Check-Ins
Structured PRO delivery tracking vasomotor, psychological, and physical symptoms throughout the treatment cycle.
- Symptoms include physical, emotional, and cognitive
- Physiological data: weight, heart rate, blood pressure, etc.
Coming soon
Hormonal Panel via Microsampling
Patient self-collects at home. Estrogen and progesterone levels returned to clinician dashboard within 5 business days.
Evidence-Based Treatment Adjustment
Clinician reviews 3-month symptom trajectory, adherence data, and lab results, adjusting dose or route with complete information.
Take the Next Step
See AppMed™ in Action in
Your Menopause Program
Request a clinical demonstration tailored to your Menopause program. We’ll show you exactly how the data works for your patient population.
Women's health specialists · 24h response · Quebec-based clinical team